Call Us for Support
+91 9654860915
Finding access to medicine unapproved in your home country can feel overwhelming. We’re here to help you navigate the process, from your initial request to procurement coordination.
Submit your details and prescription to get started.Register today to get started on your medicine access journey.
New heart and blood-vessel medicines are often approved in the US or Europe years before they reach India. This page lists the cardiology medicines we can help patients in India access through the Named Patient Program, with a valid prescription from their cardiologist or pulmonologist.
A cardiac myosin inhibitor for adults with symptomatic obstructive HCM, used under a cardiologist's supervision with regular echocardiogram checks. Read more about Camzyos in India.
A small interfering RNA (siRNA) therapy, used with diet and exercise, that lowers LDL cholesterol by reducing PCSK9 production in the liver. See Leqvio availability in India.
Two medicines for pulmonary arterial hypertension (WHO Group 1). Ventavis is an inhaled prostacyclin mimetic taken through a nebulizer; Winrevair is an activin signalling inhibitor given as an injection every 3 weeks. Read about Ventavis and Winrevair in India.
Not sure if your medicine qualifies? Send us an enquiry.